This is a working overview of drug affinity complex, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-12-23. Anything still debated is marked as such rather than presented as settled.
At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.
CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.
Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.
Naming in this area is inconsistent, and readers should treat product labels with care. In much of the literature and in vendor catalogs, the unqualified term refers to the albumin-binding version, while the version lacking the DAC group appears as modified GRF(1-29), mod GRF(1-29), or the same name with a without-DAC qualifier. Because one abbreviation has been applied to both materials, the only reliable way to identify a sample is to check the stated sequence and the presence of the linker.
CJC-1295 is the name used for a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound was described by a Canadian drug discovery company in the mid-2000s as a long-acting research tool. Two closely related molecules share the name in practice: one carries a drug affinity complex, or DAC, group, and one does not. The distinction matters because the two behave differently in circulation.
| Property | Value | Notes |
|---|---|---|
| Molecular weight, DAC form | About 3647 Da | Varies with salt form |
| Molecular weight, non-DAC form | About 3358 Da | MOD GRF(1-29) |
| Solubility class | Water soluble | Also dissolves in polar solvents |
| Reported half-life, DAC form | About five to eight days | Values from human studies |
| Common synonyms | CJC-1295; MOD GRF(1-29) | Name depends on variant |
Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
CJC-1295 is a synthetic peptide designed to mimic growth hormone-releasing hormone (GHRH), the endogenous signal that prompts the pituitary gland to release growth hormone. The compound is a modified fragment of the natural hormone, spanning the first twenty-nine amino acids of GHRH with several substitutions that slow enzymatic breakdown. Two variants circulate in research settings: one carrying a drug affinity complex (DAC) and one without it. The DAC-free form is frequently labelled Mod GRF(1-29) in catalogs and discussion forums.
The peptide binds GHRH receptors on somatotroph cells within the anterior pituitary, triggering a signalling cascade that increases growth hormone secretion. Its improved resistance to dipeptidyl peptidase IV degradation distinguishes it from the parent hormone. In the DAC-bearing version, a maleimide group reacts with a cysteine residue on serum albumin, forming a covalent bond that keeps the peptide in circulation far longer. That albumin attachment is the central design feature separating the two research variants.
For some professional career programs, students are required to take the Saber-Pro test, in their final year of undergraduate academic education. Public spending on education as a proportion of gross domestic product in 2015 was 4.49%. This represented 15.05% of total government expenditure. The primary and secondary gross enrolment ratios stood at 113.56% and 98.09% respectively. School-life expectancy was 14.42 years. A total of 94.58% of the population aged 15 and older were recorded as literate, including 98.66% of those aged 15–24.
Rindo Azami (阿左美 竜胆, Azami Rindō) Voiced by: Taku Yashiro (Japanese); Lee George (English) The Agent of Autumn's Guard. He treats his job like a business, without letting his emotions get in the way. Those around him don't see it that way. He doesn't realize it, but he's overprotective of Nadeshiko.
Simulations suggest that decreasing the spacing between the lenses so that they are less than the diameter of the smallest ring electrode could be a plausible solution to this problem. Another issue with the design is that the funnel is susceptible to noise with fast neutrals and charged droplets at many atmospheric interfaces during the initial vacuum phase. Modifications increase the efficiency and signal to noise ratio of the ion funnel. Some of the earliest ion funnels struggled to control gas flow as the pressure in the ion vacuum chamber was not uniform due to gas dynamic effects. The pressure at the funnel's exit was estimated to be 2 to 3 times higher than the pressure from the pressure gauge. The higher pressure required greater pumping in downstream vacuum chambers to compensate for the larger injection of gas. The discrepancy between the measured pressure and the pressure at the exit of the funnel was caused by the a sizable portion of the supersonic gas jet from the injector continuing beyond the Mach disk or shock diamond at the beginning of the funnel and continuing through until the end. The most effective resolution is the us of a jet disrupter that consists of a 9 mm diameter brass disk suspended perpendicular to the gas flow in the center of the ion funnel.
The Aviation Safety Reporting System (ASRS) collects voluntarily submitted aviation safety incident/situation reports from pilots, controllers and others. The ASRS uses reports to identify system deficiencies, issue alert messages, and produce two publications, CALLBACK, and ASRS Directline. The collected information is made available to the public, and is used by the FAA, NASA and other organizations working in research and flight safety.
C-5 sterol desaturase (also known as sterol C-5 desaturase and C5SD) is an enzyme that is highly conserved among eukaryotes and catalyzes the dehydrogenation of a C-5(6) bond in a sterol intermediate compound as a step in the biosynthesis of major sterols. The precise structure of the enzyme's substrate varies by species. For example, the human C-5 sterol desaturase (also known as lathosterol oxidase) oxidizes lathosterol, while its ortholog ERG3 in the yeast Saccharomyces cerevisiae oxidizes episterol.
Sources: en.wikipedia.org
Rubidium-87 has such a long half-life as to be essentially stable (longer than the age of the Earth). Rubidium-86 quickly decays to stable strontium-86 if produced either directly via (n,2n) reactions in rubidium-87, or via neutron capture in rubidium-85.
The first gene silencing approach to Alzheimer's disease is reported, with a drug called BIIB080 used on the microtubule-associated protein tau (MAPT) gene. Patients in a Phase 1 trial were found to have a greater than 50% reduction in levels of harmful tau protein after taking the drug. 26 April Astronomers present an image, for the first time viewed together, of the shadow of the black hole in the center of the Messier 87 galaxy, and its related high-energy jet. The first global assessment of glacier mass loss from satellite radar altimetry is published. It shows that glaciers lost 2,720 gigatonnes of ice, about 2% of their volume, between 2010 and 2020. 28 April – Progress in AI software: ChatGPT is shown to outperform human doctors in responding to online medical questions when measured on quality and empathy by "a team of licensed health care professionals", albeit the chatbot may have previously been trained with these reddit question and answers threads.
Most metabolic processes have a specific and narrow range of pH where operation is possible, multiple regulatory systems are in place to maintain homeostasis. Fluctuations away from optimal operating pH can slow or impair reactions and possibly cause damage to cellular structures or proteins. To maintain homeostasis the body may excrete excess acid or base through the urine, via gas exchange in the lungs, or buffer it in the blood. The bicarbonate buffering system of blood plasma effectively holds a steady pH and helps to hold extracellular pH around 7.35. The kidneys are responsible for the majority of acid-base regulation but can excrete urine no lower than a pH of 5. This means that a 330mL can of cola, for example, usually ranging in pH from 2.8 to 3.2, would need to be diluted 100 fold before being excreted. Instead of producing 33L of urine from one can of cola, the body relies on buffer to neutralize the acid. Systemic acidosis can be the result of multiple factors, not just diet. Anaerobic exercise, diabetes, AIDS, aging, menopause, inflammation, infections, tumours, and other wounds and fractures all contribute to acidosis. Blood has an average pH of 7.40 but interstitial fluid can vary. Interstitial pH of the skin, for example, is ~7.1. There is no data available for bone.
=== Industrial === Major potassium chemicals are potassium hydroxide, potassium carbonate, potassium sulfate, and potassium chloride. Megatons of these compounds are produced annually. KOH is a strong base, which is used in industry to neutralize strong and weak acids, to control pH and to manufacture potassium salts. It is also used to saponify fats and oils, in industrial cleaners, and in hydrolysis reactions, for example of esters. Potassium nitrate (KNO3) or saltpeter is obtained from natural sources such as guano and evaporites or manufactured via the Haber process; it is the oxidant in gunpowder (black powder) and an important agricultural fertilizer. Potassium cyanide (KCN) is used industrially to dissolve copper and precious metals, in particular silver and gold, by forming complexes. Its applications include gold mining, electroplating, and electroforming of these metals; it is also used in organic synthesis to make nitriles. Potassium carbonate (K2CO3 or potash) is used in the manufacture of glass, soap, color TV tubes, fluorescent lamps, textile dyes and pigments. Potassium permanganate (KMnO4) is an oxidizing, bleaching and purification substance and is used for production of saccharin. Potassium chlorate (KClO3) is added to matches and explosives. Potassium bromide (KBr) was formerly used as a sedative and in photography.
Sources: en.wikipedia.org
It is a synthetic peptide modeled on growth hormone-releasing hormone. The molecule is used in research on pituitary growth hormone secretion. It differs from the natural hormone through several stabilizing substitutions.
The DAC form carries a maleimide group that binds albumin and extends circulation time. The non-DAC form lacks this group and clears much faster. Both share the same receptor-binding core.
It targets the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Activation raises cyclic AMP and promotes growth hormone release. Normal feedback pathways remain part of the response.
No. It is a laboratory-made analog of growth hormone-releasing hormone. The natural hormone is a 44-residue peptide, while the analog is built on a shorter 29-residue fragment.